Incidence of C5 palsy in anterior cervical decompression & fusion, posterior cervical decompression & fusion and laminoplasty for degenerative cervical myelopathy: systematic review and meta-analysis of 21,231 cases

Article information

Asian Spine J. 2025;.asj.2025.0220
Publication date (electronic) : 2025 September 29
doi : https://doi.org/10.31616/asj.2025.0220
1Orthopaedic Research Group, Coimbatore, India
2Central Research Laboratory, Meenakshi Medical College Hospital and Research Institute, Meenakshi Academy of Higher Education and Research, Chennai, India
3Spine Division, Department of Orthopaedics, Meenakshi Mission Hospital, Madurai, India
4Department of Orthopaedics, Government Medical College, Namakkal, India
5Department of Orthopaedics, Devadoss Hospital, Madurai, India
Corresponding author: Sathish Muthu, Department of Spine Surgery, Orthopaedic Research Group, Coimbatore, Tamil Nadu, India Tel: +91-9600856806, E-mail: drsathishmuthu@gmail.com
Received 2025 April 16; Revised 2025 May 23; Accepted 2025 May 24.

Abstract

C5 palsy (C5P) is a common, yet poorly understood complication of cervical decompressive surgery, causing substantial disability and impacting postoperative quality of life. Despite extensive research, the actual incidence and distribution of C5P across different cervical surgical approaches over the past decade remain unclear. A comprehensive literature search was conducted on October 15, 2024, across Google Scholar, Embase, PubMed, Web of Science, and Cochrane Library databases. Studies reporting C5P incidence following surgery for degenerative cervical conditions, published until 2024, were included, excluding reviews, opinions, letters, and non-English manuscripts. Ninety-seven articles were included, encompassing 21,231 patients undergoing decompressive cervical surgery for degenerative cervical myelopathy. The overall incidence of postoperative C5P was 7% (95% confidence interval [CI], 4%–10%). The highest incidence was observed with circumferential fusion (combined anterior-posterior approach) at 16% (95% CI, 8%–24%), while the lowest was with anterior cervical decompression and fusion at 4% (95% CI, 3%–5%). Incidence rates following laminoplasty and laminectomy and fusion were 6% (95% CI, 5%–7%) and 10% (95% CI, 8%–12%), respectively. Recovery time ranged from 20.9 to 35 weeks, with 19.1%–33% of patients experiencing residual weakness. Significant risk factors included male sex, preoperative intervertebral foraminal stenosis, ossified posterior longitudinal ligament, open-door laminoplasty, laminectomy (with/without fusion), and excessive spinal cord shift. The role of C4–5 foraminotomy remains contested. Our meta-analysis identifies the posterior surgical approach as a significant risk factor for C5P. Circumferential fusion poses the highest risk, while laminoplasty can reduce the risk compared to laminectomy (alone or with instrumented fusion).

Introduction

C5 palsy (C5P) is a recognized complication of cervical spine surgery, with incidence rates ranging from 5% to 10% [1]. Although traditionally associated with posterior cervical surgical approaches, such as laminoplasty (LP) and laminectomy (with or without fusion), C5P has also been reported in anterior cervical decompression and fusion (ACDF) surgeries [2-7]. C5P has broadly been defined as the de novo occurrence or worsening of isolated motor weakness involving the C5 myotome (or deterioration in the muscle strength of deltoid or biceps brachii by at least one grade in manual muscle testing [MMT]), without any deterioration in lower extremity function or sensory disturbances [3,8-12]. It primarily manifests as weakness of the deltoid, biceps brachii, and supinator muscles. Although unilateral involvement is typically described, the condition can occur bilaterally [13-15].

Among the C5–T1 nerve roots contributing to the brachial plexus, the C5 root is most frequently associated with post-surgical segmental palsy [16]. Despite unclear etiopathogenesis, several factors have been implicated, including iatrogenic C5 nerve root injury, thermal injury during bone drilling, ischemia of the cervical spinal cord, tethering of the C5 nerve root due to spinal cord shift after decompression, root compression within the neural foramina, and reperfusion-related cord injury [16,17].

Several studies have examined the incidence, etiological factors, and prognosis of C5P. However, the true incidence of this complication following cervical decompressive surgeries, and its variations across different surgical approaches (anterior versus posterior, fusion versus non-fusion) and technical factors (surgical technique and number of segments of decompression), remains unclear [2,4,6,8,12,15,16,18]. This meta-analysis was conducted to synthesize the large body of evidence on C5P and assess its incidence and distribution across diverse cervical decompressive surgical approaches.

Methods

The study was conducted in accordance with the Cochrane Collaboration guidelines for systematic reviews [19] and Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines [20].

Literature search

A comprehensive literature search was conducted on October 15, 2024, across five databases (Google Scholar, Embase, PubMed, Web of Science, and Cochrane Library). Studies published through 2024 that reported on the incidence of C5P in patients undergoing cervical decompression were reviewed. The search utilized keywords combined with Boolean operators: (((ACDF) OR (cervical fusion) OR (laminoplasty) OR (circumferential fusion) OR (posterior decompression)) AND (C5 palsy)).

Inclusion and exclusion criteria

Studies reporting on the occurrence, management, or recovery of C5P following decompressive surgery for degenerative cervical myelopathy were considered. Narrative or systematic reviews, opinions, letters to the editor, and non-English publications were excluded. The article selection criteria are summarized in Table 1.

Inclusion and exclusion criteria of selection of articles to be included in the review

Manuscript selection and data extraction

The search results were downloaded, imported into EndNote (Clarivate, Philadelphia, PA, USA), and deduplicated. Two authors independently screened titles, followed by a separate screening of manuscripts based on the aforementioned criteria. Full-text manuscripts were then reviewed in duplicate, and final article selection was completed. For studies with overlapping patient cohorts from the same center, only the most relevant sample was included. Discrepancies among the authors were resolved through discussion with the senior author.

Quality assessment

The methodological quality of the included studies was assessed using the Newcastle Ottawa Scale for non-randomized studies (Table 2). Only studies with adequate methodological quality were included in the analysis.

Quality assessment of the included studies

Statistical analysis

The meta-analysis was conducted using Stata ver. 16.0 software (Stata Corp., College Station, TX, USA). The reported incidence of C5P was pooled, and the mean incidence was calculated with a 95% confidence interval (CI). A random-effects model was used for data synthesis when heterogeneity was high (I2>50% and p<0.10). Otherwise, a fixed-effects model was applied. Sensitivity and subgroup analyses were performed when heterogeneity was detected. Publication bias was assessed using Egger’s regression test. A p-value less than 0.05 was considered indicative of statistical significance for all statistical analyses.

Results

The literature search yielded 3,903 articles. After deduplication and screening, 2,247 manuscripts were assessed. After screening of titles, 244 manuscripts qualified for the next level of screening. Following abstract and full-text review, 97 articles were selected for the systematic review. The study selection process is illustrated in the PRISMA flow diagram (Fig. 1). The general characteristics and outcomes of the included studies are summarized in Table 3. A total of 21,231 patients who underwent surgery for cervical myelopathy were analyzed in the included studies. Most studies were retrospective (n=86 [88.7%]). Follow-up periods ranged from 1 month to 12 years (Table 3).

Fig. 1.

PRISMA (Preferred Reporting Items for Systematic reviews and Meta-Analyses) flow diagram of inclusion of studies.

General characteristics of studies included in the review

Etiopathogenesis of C5P

Wang et al. [17,21] described C5P as a disorder or insult to the nerve root or segmental spinal cord. Five major etiopathogenic mechanisms were suggested, namely inadvertent nerve root injury, nerve root traction secondary to cord shift, segmental cord disorder, spinal cord ischemia, and reperfusion cord injury [12,17,21-23]. The main purported hypotheses underlying the higher prevalence of C5P in posterior decompressive surgeries include the “tethering phenomenon” (or posterior shift of spinal cord leading to C5 nerve root traction) and spinal cord expansion secondary to acute canal decompression [17,24].

The C5 nerve roots are particularly vulnerable due to their short length, relatively less laxity, location at the apex of cervical lordosis (which exposes them to the highest strain during spinal cord shift), proximity to the C5 superior articular process (which is more anteriorly protruded), and horizontal orientation [4,25]. These factors increase their risk of injury from traction or stretch compared to the other subaxial roots [10,13,26- 29]. Bydon et al. [10] found a 3-fold higher posterior cord shift at C4–5 level in patients with C5P, limiting the nerve root’s accommodation to the shift. Pennington et al. [13] demonstrated an axonotmesis-like nerve injury in these palsies, which explains the mean 6- to 12-month recovery period for weakness.

Incidence of C5P

The pooled incidence of C5P from 97 studies (21,231 patients) was 7% (95% CI, 4%–10%) (Fig. 2), analyzed using a random-effects model due to heterogeneity across studies.

Fig. 2.

Forest plot showing the pooled incidence of C5 palsy following surgery for cervical myelopathy. ACDF, anterior cervical decompression and fusion; PCDF, posterior cervical decompression and fusion; LP, laminoplasty; CI, confidence interval; REML, restricted maximum likelihood.

Subgroup analysis

A subgroup analysis was performed based on the surgical procedure, including ACDF, posterior cervical decompression and fusion (PCDF), LP, and combined anterior and posterior fusion (circumferential fusion). Upon subgroup analysis, the incidence rates were 4% (95% CI, 3%–5%) for ACDF (Fig. 3), 6% (95% CI, 5%–7%) with LP (Fig. 4), 10% (95% CI, 8%–12%) for PCDF (or laminectomy and fusion [LF]) (Fig. 5), and 16% (95% CI, 8%–24%) for circumferential fusion (Fig. 6).

Fig. 3.

Forest plot showing the incidence of C5 palsy following anterior cervical decompression and fusion surgery for cervical myelopathy. ES, effect size; CI, confidence interval.

Fig. 4.

Forest plot showing the incidence of C5 palsy following laminoplasty surgery for cervical myelopathy. ES, effect size; CI, confidence interval.

Fig. 5.

Forest plot showing the incidence of C5 palsy following posterior decompression and fusion surgery for cervical myelopathy. ES, effect size; CI, confidence interval.

Fig. 6.

Forest plot showing the incidence of C5 palsy following global decompression and fusion surgery for cervical myelopathy. ES, effect size; CI, confidence interval.

Risk factors for C5P

Various studies have examined the risk factors for C5P in patients undergoing cervical spinal surgeries [16,30,31]. Pennington et al. [13] found that mean foraminal diameter (p<0.001) and gait disturbance at the initial consultation (p=0.008) were significant predictors of postoperative C5P. A preoperative foraminal diameter <2 mm was associated with a twofold higher incidence of C5P. In addition, preoperative symptoms such as tingling or numbness (p=0.08) and inadvertent dropping of objects (p=0.09) tended toward significance, but were not statistically significant in multivariate analysis. In the study by Wang et al. [17,21], the C5P rate was substantially higher in males (5.9% vs. 4.1%). They also found unilateral involvement to be substantially more common.

Several radiological parameters have been purported to predict C5P with a high specificity and sensitivity, including reduced anteroposterior canal dimension, decreased intervertebral foraminal size, and high cervical lordosis angle (open angle of lamina) [32-34]. Lubelski et al. [35] studied 98 patients undergoing anterior or posterior decompression at the C4–5 level and found a significant impact of the severity of preoperative C4–5 foraminal stenosis on the occurrence of postsurgical C5P. Notably, each 1 mm increase in foraminal size reduced the risk of developing palsy by 50-fold.

Other potential risk factors include inadequate restoration of cervical lordosis or alignment, severity of myelopathy (measured by Japanese Orthopaedic Association scores) and high-intensity spinal cord signal on T2-weighted image. However, the impact of these factors remains debated [36-39]. Egger’s regression test showed no significant publication bias among the included studies (p=0.521).

Discussion

C5P was first described by Scoville [40] in the 1960s as a complication of cervical decompressive surgery. It can present immediately following surgery (typically at or after 24 hours) or even up to 2 months postoperatively. While the prognosis is usually good, the recovery time can substantially vary depending on the severity of the neurodeficit [15,41]. In the short term, C5P significantly impairs the quality of life, decreases patient satisfaction, and increases the overall healthcare-related expenditure. Conservative treatment strategies for C5P include rest, muscle rehabilitation, drug therapy (such as high-dose corticosteroids), dehydration therapy, and hyperbaric oxygen therapy [8,11,15,21,26,42]. This systematic review aimed to comprehensively review recent literature and analyze the incidence rate of this adverse event across various surgical approaches.

Definitions of C5P

There is a significant variation in the definitions for C5P across studies, which can potentially impact the reported incidence rates. Imagama et al. [4] defined C5P as a postoperative deltoid muscle strength of 0–2 on the MMT, with or without weakness of biceps brachii, while other muscles remain unaffected. Nakashima et al. [43] defined it as a ≥1 grade deterioration in deltoid muscle on MMT, with or without biceps brachii involvement. Nassr et al. [14] described C5P as loss of motor power in the deltoid and/or biceps, sensory impairment in the C5 dermatome, and increased pain in the C5 distribution. Nakamae et al. [44] defined C5P as a palsy in the deltoid and biceps musculature with a ≥1 grade decrease in MMT without sensory impairment.

Incidence of C5P

In the study by Shou et al. [45], the mean incidence of C5P was 5.3% (95% CI, 4.6%–6.0%), while the incidence varied between 0 and 30% in the study by Sakaura et al. [12] In the meta-analysis by Wang et al. [17], the pooled mean incidence of C5P was 6.3% (95% CI, 5.7%–7.9%), with the mean rate ranging between 1% and 29% across the reviewed studies. The meta-analysis by Wang et al. [17,21] found C5P incidence rates of 6.2% for posterior cervical approaches and 5% for anterior cervical spinal approaches. Most studies suggest a relatively higher incidence of C5P with posterior cervical procedures. In the increasing order of frequency, the reported incidence of C5P in patients undergoing LP, ACDF, anterior cervical corpectomy with discectomy and fusion (ACCDF)–hybrid procedure, anterior cervical corpectomy and fusion (ACCF), and LF were 4.4%, 5.5%, 6%, 7.5% and 13%, respectively. In our meta-analysis, the overall pooled mean incidence of C5P was 7% (95% CI, 4%–10%).

Underlying pathological diagnosis and C5F

Wang et al. [17,21] compared the incidence of C5P across diverse cervical degenerative pathologies. They found a significantly higher incidence of C5P in patients with ossified posterior longitudinal ligament (OPLL) at 8.1%, compared to those with cervical spondylomyelopathy (CSM) at 4.8%. In their study, patients with OPLL had higher C5P rates than those with CSM when undergoing ACDF (5.5% vs. 4.7%) and LP (8.1% vs. 3.1%), but similar rates when undergoing LF (13% vs. 13.1%) [17,25]. The higher incidence of C5P in OPLL patients has been attributed to the greater spinal cord shifting, resulting in a stronger tethering effect on the nerve roots [16]. A meta-analysis by Shou et al. [45] involving 13,621 patients from 79 studies, identified male sex and LF as key risk factors for C5P. Another meta-analysis identified male sex, preoperative intervertebral foraminal stenosis, underlying OPLL, laminectomy, and excessive spinal cord shift as significant risk factors for C5P in patients undergoing posterior cervical procedures [25].

Surgical approaches and C5P

The multicenter, prospective, randomized phase-3 CSM-protect trial found that the posterior approach was independently associated with at least 4-fold greater risk of developing postoperative C5P compared to the anterior approach [24]. In our study, subgroup analysis showed ACDF had the lowest incidence of C5P (4%; 95% CI, 3%–5%), while circumferential fusion (combined anterior-posterior) carried the highest risk for C5P (16%; 95% CI, 8%–24%]). In a meta-analysis by Takase et al. [8,11] involving patients who underwent 3 to 6 level anterior cervical decompression, the incidence of late C5P was 4.2%. The incidence rates following ACDF, ACCDF-hybrid, and ACCF procedures were 2.3%, 3.9%, and 6.4%, respectively. Based on network meta-analysis, they concluded that ACCF was associated with a substantially higher risk of C5P compared to ACDF, recommending ACDF as the preferred option for long-segment cervical fusions when feasible. Broadly, our study also demonstrated relatively higher rates of C5P following posterior decompressive surgeries, compared to anterior approaches.

The meta-analysis by Wang et al. [17,21] found that LF was associated with a significantly higher incidence of C5P (p=0.004) and higher Neck Disability Index (p<0.001) compared to LP. Based on a single-surgeon experience, Kim et al. [3] concluded that LP was associated with a significantly lower incidence of C5P compared to LF (p=0.01) [7]. However, analysis of data from the National Registry showed no significant difference between LP and LF in this respect, suggesting that surgeon experience and training may impact complication rates [46]. Our study also found relatively higher rates of C5P following LF or PDCF, in comparison with LP (6% [95% CI, 5%–7%] for LP vs. 10% [95% CI, 8%–12%] for PDCF or LF).

The types of LP described include cervical expansile open-door LP (EOLP), Hirabayashi, Z-type, double-door, and spinous-process splitting-type LP. A large-scale study by Levy et al. [47] on EOLP found C5P to be the most common complication, occurring in 2.6% of patients. Notably, C5P in LP was more common on the open-door side of the lamina compared to the hinge side, likely due to the potentially greater tethering effect on the open side. They recommended creating the hinge on the patient’s dominant arm side to minimize the risk of loss of dominant arm function. A systematic review by Gu et al. [25] found that open-door LP had a higher incidence of C5P, compared to double-door LP, likely due to cord rotation from asymmetric spinal decompression, resulting in greater tethering on the open side [4,5,25,48]. On the contrary, a large-scale, multicenter study by Imagama et al. [4] found no significant difference in C5P rates between open-door and double-door LP.

C4–5 foraminotomy and its role in C5P

Sasai et al. [49] identified the presence of preoperative C5 radiculopathy (which may correlate with the degree of C4–5 foraminal stenosis) as a crucial predictor of palsy. In this context, the impact of C4–5 foraminotomy on postoperative C5P has been widely debated. Studies by Katsumi et al. [50], Komagata et al. [51], and Sasai et al. [49] supported the role of prophylactic C4–5 foraminotomy in reducing the risk of C5P, attributing the benefit to the reduction in the nerve root anchorage at the site of intervertebral foramen. However, other studies have demonstrated significantly increased C5P rates after intraoperative manipulation of the nerve root and C4–5 foraminotomy. Pennington et al. [13] suggested that the C5 nerve root’s susceptibility to injury during decompression may be due to the small size of the C4–5 foramen and the horizontal orientation of the C5 nerve root, which can put it in line with the long axis of the Kerrison’s rongeur during decompression, increasing the risk of impingement by the instrument [52].

Predicting the outcome following C5P

In the study by Lubelski et al. [53], deltoid strength improvement was found to predict recovery from C5P. They observed that patients who experienced complete (overall 60%) or partial recovery (29% of cases) demonstrated improvement in motor power by at least one Medical Research Council (MRC) grade at approximately 6 weeks following the deficit. They underlined the significance of examination at 6 weeks’ time point to predict any meaningful recovery, since the motor power of grade 4/5 or greater at 6 weeks was predictive of complete recovery. On the other hand, patients who gained strength of 3/5 or below in the antigravity muscles alone exhibited only partial recovery. In short, the cohort with little or no recovery within 6 weeks of the onset of C5P was unlikely to experience good long-term outcomes. In addition, electrophysiological testing, such as electromyography, can help identify patients with postoperative C5P who are unlikely to experience meaningful recovery.

A study by Saadeh et al. [54] found that among patients with severe C5P (defined by antigravity strength of MRC grade ≤2) at 3 months postoperatively, 50% regained useful strength by 12 months. However, for those with persistently severe C5P at 6 months, only 25% recovered sufficient strength by 12 months. Patients with MRC grades 0 or 1 at 6 months did not regain useful strength by 1 year. In their series, female sex was associated with good recovery, while those with diabetes mellitus had significantly poorer outcomes.

Lim et al. [2] investigated 36 patients who developed C5P following cervical decompression surgery. They found that 50% of patients (among whom, 91.7% recovered between 6 months and 2 years, while 8.3% did not recover until 2 years) required longer than 6 months to experience useful neurological recovery. The factors associated with longer recovery (>6 months) included motor grade ≤2 (p<0.001), multi-segment paresis involving segments apart from C5 root (p=0.002), extent of posterior spinal cord shift (p=0.04), and the absence of somatic sensation with pain (p=0.008).

Pennington et al. [13,55] found that patients who underwent C4–5 foraminotomy were more likely to develop permanent C5 deficit (p=0.004). Other radiological parameters, such as mean cord-lamina angle and length of laminectomy, showed trends toward significance (p=0.06 and p=0.08, respectively) but did not reach statistical significance.

Factors underlying delayed or compromised neurological recovery

Hashimoto et al. [56] suggested that pre-existing, asymptomatic damage to the anterior horn cells in the spinal cord gray matter may contribute to the development of severe postoperative C5P. Severe C5 palsies are known to have slower and poorer neurological recovery. Additionally, multilevel paresis has been associated with poor outcomes, potentially due to focal reperfusion injury to the spinal cord following spinal decompression [38]. Similarly, significant sensory involvement (>50%) and intractable pain may indicate severe spinal cord injury or ischemia/reperfusion injury, which are associated with poor prognosis in patients with C5P.

Limitations

Our study has limitations, including the exclusion of non-English publications, which may have led to missed relevant articles. Additionally, the predominantly retrospective nature of the included studies reduces the level of evidence. However, given the focus on complications from surgical interventions, retrospective case-control studies are often the primary source of data, limiting the availability of higher-quality evidence from randomized controlled trials. The study’s results may be influenced by the overlapping nature of some of the reviewed parameters, such as circumferential fusion being usually performed on patients with more severe pathologies. Additionally, certain factors like aggressive shoulder retraction or shoulder taping during positioning, which could impact outcomes, were beyond the purview of this review.

Conclusions

Our meta-analysis found that the posterior surgical approach is a significant risk factor for C5P. Circumferential (or combined anteroposterior) fusion carries the greatest risk of developing the palsy. Among posterior approaches, LP may reduce the risk of C5P compared to laminectomy, with or without instrumented fusion.

Key Points

  • C5 palsy occurred in 7% of cases overall, with the highest rates seen in circumferential fusion (16%) and posterior approaches (10%), compared to 4% in anterior cervical decompression and fusion.

  • Male sex, severe foraminal stenosis (<2 mm), ossified posterior longitudinal ligament, and excessive spinal cord shift were consistently associated with higher C5 palsy risk.

  • Reduced canal diameter and steep cervical lordosis angle emerged as significant imaging markers for vulnerability.

  • Mean recovery time ranged from 21 to 35 weeks, and up to one-third of patients had persistent weakness, especially if deltoid strength was poor at 6 weeks.

  • While some evidence supports prophylactic C4–5 foraminotomy, others caution against it due to potential intraoperative nerve manipulation.

Notes

Conflict of Interest

No potential conflict of interest relevant to this article was reported.

Acknowledgments

Data generated in the study will be made available upon reasonable request to the authors

Author Contributions

Conceptualization: S. Muthu, VKV. Design of the study: S. Muthu, VKV. Methodology and statistical framework: S. Muthu. Data collection: S. Munisamy, GPK. Data curation: GPK. Resources: S. Muthu. Data verification and accuracy check: S. Muthu, VKV. Writing–original draft preparation: S. Muthu. Writing–review and editing: VKV. Visualization and creation of figures: S. Muthu. Supervision and coordination of the project: S. Muthu. Final approval of the manuscript: all authors.

References

1. Takase H, Haze T, Yamamoto D, et al. Network meta-analysis of C5 palsy after anterior cervical decompression of three to six levels: comparing three different procedures. Spine (Phila Pa 1976) 2024;49:188–96.
2. Lim CH, Roh SW, Rhim SC, Jeon SR. Clinical analysis of C5 palsy after cervical decompression surgery: relationship between recovery duration and clinical and radiological factors. Eur Spine J 2017;26:1101–10.
3. Kim S, Lee SH, Kim ES, Eoh W. Clinical and radiographic analysis of c5 palsy after anterior cervical decompression and fusion for cervical degenerative disease. J Spinal Disord Tech 2014;27:436–41.
4. Imagama S, Matsuyama Y, Yukawa Y, et al. C5 palsy after cervical laminoplasty: a multicentre study. J Bone Joint Surg Br 2010;92:393–400.
5. Kaneyama S, Sumi M, Kanatani T, et al. Prospective study and multivariate analysis of the incidence of C5 palsy after cervical laminoplasty. Spine (Phila Pa 1976) 2010;35:E1553–8.
6. Katsumi K, Yamazaki A, Watanabe K, Ohashi M, Shoji H. Can prophylactic bilateral C4/C5 foraminotomy prevent postoperative C5 palsy after open-door laminoplasty?: a prospective study. Spine (Phila Pa 1976) 2012;37:748–54.
7. Lee SH, Suk KS, Kang KC, et al. Outcomes and related factors of C5 palsy following cervical laminectomy with instrumented fusion compared with laminoplasty. Spine (Phila Pa 1976) 2016;41:E574–9.
8. Takase H, Tayama K, Nakamura Y, et al. Anterior cervical decompression and C5 palsy: a systematic review and meta-analysis of three reconstructive surgeries. Spine (Phila Pa 1976) 2020;45:1587–97.
9. Ikenaga M, Shikata J, Tanaka C. Radiculopathy of C-5 after anterior decompression for cervical myelopathy. J Neurosurg Spine 2005;3:210–7.
10. Bydon M, Macki M, Kaloostian P, et al. Incidence and prognostic factors of c5 palsy: a clinical study of 1001 cases and review of the literature. Neurosurgery 2014;74:595–605.
11. Takase H, Murata H, Sato M, et al. Delayed C5 palsy after anterior cervical decompression surgery: preoperative foraminal stenosis and postoperative spinal cord shift increase the risk of palsy. World Neurosurg 2018;120:e1107–19.
12. Sakaura H, Hosono N, Mukai Y, Ishii T, Yoshikawa H. C5 palsy after decompression surgery for cervical myelopathy: review of the literature. Spine (Phila Pa 1976) 2003;28:2447–51.
13. Pennington Z, Lubelski D, D’Sa A, et al. Preoperative clinical and radiographic variables predict postoperative C5 palsy. World Neurosurg 2019;127:e585–92.
14. Nassr A, Eck JC, Ponnappan RK, Zanoun RR, Donaldson WF 3rd, Kang JD. The incidence of C5 palsy after multilevel cervical decompression procedures: a review of 750 consecutive cases. Spine (Phila Pa 1976) 2012;37:174–8.
15. Thompson SE, Smith ZA, Hsu WK, et al. C5 palsy after cervical spine surgery: a multicenter retrospective review of 59 cases. Global Spine J 2017;7(1 Suppl):64S–70S.
16. Chen G, Wang Y, Wang Z, Zhu R, Yang H, Luo Z. Analysis of C5 palsy in cervical myelopathy with massive anterior compression following laminoplasty. J Orthop Surg Res 2018;13:26.
17. Wang T, Wang H, Liu S, Ding WY. Incidence of C5 nerve root palsy after cervical surgery: a meta-analysis for last decade. Medicine (Baltimore) 2017;96e8560.
18. Nori S, Aoyama R, Ninomiya K, et al. Cervical laminectomy of limited width prevents postoperative C5 palsy: a multivariate analysis of 263 muscle-preserving posterior decompression cases. Eur Spine J 2017;26:2393–403.
19. Higgins JP, Thomas J, Chandler J, et al. Cochrane handbook for systematic reviews of interventions Hoboken (NJ): Wiley; 2019.
20. Page MJ, Moher D, Bossuyt PM, et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ 2021;372:n160.
21. Wang J, Wo J, Wen J, Zhang L, Xu W, Wang X. Laminoplasty versus laminectomy with fusion for treatment of multilevel cervical compressive myelopathy: an updated meta-analysis. Postgrad Med J 2022;98:680–8.
22. Hirabayashi K, Satomi K. Operative procedure and results of expansive open-door laminoplasty. Spine (Phila Pa 1976) 1988;13:870–6.
23. Tsuzuki N, Abe R, Saiki K, Zhongshi L. Extradural tethering effect as one mechanism of radiculopathy complicating posterior decompression of the cervical spinal cord. Spine (Phila Pa 1976) 1996;21:203–11.
24. Bak AB, Moghaddamjou A, Alvi M, et al. Postoperative C5 palsy after anterior or posterior decompression for degenerative cervical myelopathy: a subgroup analysis of the multicenter, prospective, randomized, phase III, CSM-protect clinical trial. Spine (Phila Pa 1976) 2024;49:1410–6.
25. Gu Y, Cao P, Gao R, et al. Incidence and risk factors of C5 palsy following posterior cervical decompression: a systematic review. PLoS One 2014;9e101933.
26. Nakajima H, Kuroda H, Watanabe S, Honjoh K, Matsumine A. Risk factors and preventive measures for C5 palsy after cervical open-door laminoplasty. J Neurosurg Spine 2019;32:592–9.
27. Baba S, Ikuta K, Ikeuchi H, et al. Risk factor analysis for C5 palsy after double-door laminoplasty for cervical spondylotic myelopathy. Asian Spine J 2016;10:298–308.
28. Hwang JC, Bae HG, Cho SW, Cho SJ, Park HK, Chang JC. Morphometric study of the nerve roots around the lateral mass for posterior foraminotomy. J Korean Neurosurg Soc 2010;47:358–64.
29. Jack A, Ramey WL, Dettori JR, et al. Factors associated with C5 palsy following cervical spine surgery: a systematic review. Global Spine J 2019;9:881–94.
30. Chang PY, Chan RC, Tsai YA, et al. Quantitative measures of functional outcomes and quality of life in patients with C5 palsy. J Chin Med Assoc 2013;76:378–84.
31. Chen Y, Guo Y, Lu X, et al. Surgical strategy for multilevel severe ossification of posterior longitudinal ligament in the cervical spine. J Spinal Disord Tech 2011;24:24–30.
32. Takemitsu M, Cheung KM, Wong YW, Cheung WY, Luk KD. C5 nerve root palsy after cervical laminoplasty and posterior fusion with instrumentation. J Spinal Disord Tech 2008;21:267–72.
33. Yang L, Gu Y, Shi J, et al. Modified plate-only open-door laminoplasty versus laminectomy and fusion for the treatment of cervical stenotic myelopathy. Orthopedics 2013;36:e79–87.
34. Zhang H, Lu S, Sun T, Yadav SK. Effect of lamina open angles in expansion open-door laminoplasty on the clinical results in treating cervical spondylotic myelopathy. J Spinal Disord Tech 2015;28:89–94.
35. Lubelski D, Derakhshan A, Nowacki AS, et al. Predicting C5 palsy via the use of preoperative anatomic measurements. Spine J 2014;14:1895–901.
36. Hatta Y, Shiraishi T, Hase H, et al. Is posterior spinal cord shifting by extensive posterior decompression clinically significant for multisegmental cervical spondylotic myelopathy? Spine (Phila Pa 1976) 2005;30:2414–9.
37. Shiozaki T, Otsuka H, Nakata Y, et al. Spinal cord shift on magnetic resonance imaging at 24 hours after cervical laminoplasty. Spine (Phila Pa 1976) 2009;34:274–9.
38. Chiba K, Toyama Y, Matsumoto M, Maruiwa H, Watanabe M, Hirabayashi K. Segmental motor paralysis after expansive open-door laminoplasty. Spine (Phila Pa 1976) 2002;27:2108–15.
39. Sodeyama T, Goto S, Mochizuki M, Takahashi J, Moriya H. Effect of decompression enlargement laminoplasty for posterior shifting of the spinal cord. Spine (Phila Pa 1976) 1999;24:1527–32.
40. Scoville WB. Cervical spondylosis treated by bilateral facetectomy and laminectomy. J Neurosurg 1961;18:423–8.
41. Miller JA, Lubelski D, Alvin MD, Benzel EC, Mroz TE. C5 palsy after posterior cervical decompression and fusion: cost and quality-of-life implications. Spine J 2014;14:2854–60.
42. Rai V, Sharma V, Kumar M, Thakur L. A systematic review of risk factors and adverse outcomes associated with anterior cervical discectomy and fusion surgery over the past decade. J Craniovertebr Junction Spine 2024;15:141–52.
43. Nakashima H, Imagama S, Yukawa Y, et al. Multivariate analysis of C-5 palsy incidence after cervical posterior fusion with instrumentation. J Neurosurg Spine 2012;17:103–10.
44. Nakamae T, Tanaka N, Nakanishi K, et al. Investigation of segmental motor paralysis after cervical laminoplasty using intraoperative spinal cord monitoring with transcranial electric motor-evoked potentials. J Spinal Disord Tech 2012;25:92–8.
45. Shou F, Li Z, Wang H, Yan C, Liu Q, Xiao C. Prevalence of C5 nerve root palsy after cervical decompressive surgery: a meta-analysis. Eur Spine J 2015;24:2724–34.
46. Kim J, Shankar DS, Bienstock DM, et al. Postoperative C5 palsy following cervical laminectomy with instrumented fusion versus cervical laminoplasty with reconstruction: single surgeon and national inpatient cohort analyses. Clin Spine Surg 2022;35:181–6.
47. Levi DJ, Brusko GD, Levi AD, Wang MY. Does hinge sidedness influence laterality of C5 palsy after expansile open-door cervical laminoplasty? Neurosurg Focus 2023;55:E6.
48. Park JH, Roh SW, Rhim SC, Jeon SR. Long-term outcomes of 2 cervical laminoplasty methods: midline splitting versus unilateral single door. J Spinal Disord Tech 2012;25:E224–9.
49. Sasai K, Saito T, Akagi S, Kato I, Ohnari H, Iida H. Preventing C5 palsy after laminoplasty. Spine (Phila Pa 1976) 2003;28:1972–7.
50. Katsumi K, Yamazaki A, Watanabe K, Ohashi M, Shoji H. Analysis of C5 palsy after cervical open-door laminoplasty: relationship between C5 palsy and foraminal stenosis. J Spinal Disord Tech 2013;26:177–82.
51. Komagata M, Nishiyama M, Endo K, Ikegami H, Tanaka S, Imakiire A. Prophylaxis of C5 palsy after cervical expansive laminoplasty by bilateral partial foraminotomy. Spine J 2004;4:650–5.
52. Vonck CE, Tanenbaum JE, Smith GA, Benzel EC, Mroz TE, Steinmetz MP. National trends in demographics and outcomes following cervical fusion for cervical spondylotic myelopathy. Global Spine J 2018;8:244–53.
53. Lubelski D, Pennington Z, Planchard RF, et al. Use of electromyography to predict likelihood of recovery following C5 palsy after posterior cervical spine surgery. Spine J 2021;21:387–96.
54. Saadeh YS, Chopra Z, Olsen E, et al. Optimal timing of referral for nerve transfer surgery for postoperative C5 palsy. J Neurosurg Spine 2022;37:563–8.
55. Pennington Z, Lubelski D, Westbroek EM, et al. Time to recovery predicted by the severity of postoperative C5 palsy. J Neurosurg Spine 2019;32:191–9.
56. Hashimoto M, Mochizuki M, Aiba A, et al. C5 palsy following anterior decompression and spinal fusion for cervical degenerative diseases. Eur Spine J 2010;19:1702–10.

Article information Continued

Fig. 1.

PRISMA (Preferred Reporting Items for Systematic reviews and Meta-Analyses) flow diagram of inclusion of studies.

Fig. 2.

Forest plot showing the pooled incidence of C5 palsy following surgery for cervical myelopathy. ACDF, anterior cervical decompression and fusion; PCDF, posterior cervical decompression and fusion; LP, laminoplasty; CI, confidence interval; REML, restricted maximum likelihood.

Fig. 3.

Forest plot showing the incidence of C5 palsy following anterior cervical decompression and fusion surgery for cervical myelopathy. ES, effect size; CI, confidence interval.

Fig. 4.

Forest plot showing the incidence of C5 palsy following laminoplasty surgery for cervical myelopathy. ES, effect size; CI, confidence interval.

Fig. 5.

Forest plot showing the incidence of C5 palsy following posterior decompression and fusion surgery for cervical myelopathy. ES, effect size; CI, confidence interval.

Fig. 6.

Forest plot showing the incidence of C5 palsy following global decompression and fusion surgery for cervical myelopathy. ES, effect size; CI, confidence interval.

Table 1.

Inclusion and exclusion criteria of selection of articles to be included in the review

Inclusion criteria Exclusion criteria
Patient Patients with cervical myelopathy due to degenerative causes Patient with cervical myelopathy due to other causes such as trauma, tumor, infection, or inflammatory conditions
Intervention Decompressive surgery -
Comparison None -
Outcome C5 palsy incidence -
Time frame Since inception till 2024 -
Study design Clinical studies of both prospective and retrospective nature, from case reports, case series to randomized controlled trials -
Language English Non-English

Table 2.

Quality assessment of the included studies

No. Author Year Selection
Comparability Outcome
Representativeness Non-exposed cohort Exposure Outcome at study initiation Assessment Follow-up for outcome Follow-up adequacy
1 K Yonenobu 1991 * * * * * * *
2 N Tsuzuki 1993 * * * * * * *
3 K Satomi 1994 * * * * * * *
4 Y Uematsu 1998 * * * * * * *
5 K Hirabayashi 1999 * * * * * * *
6 CC Edwards 2000 * * * * * * * *
7 E Wada 2001 * * * * * * * *
8 K Chiba 2002 * * * * * *
9 M Ikenaga 2005 * * * * * * *
10 K Kaneko 2006 * * * * * * * *
11 Y Liu 2009 * * * * * * * *
12 M Hashimoto 2010 * * * * * * * *
13 M Yanase 2010 * * * * * * *
14 X Guo 2010 * * * * * * * *
15 XF Lian 2010 * * * * * * * *
16 K Kotil 2011 * * * * * * * *
17 X Zhao 2011 * * * * * * * *
18 JM Highsmith 2011 * * * * * * *
19 Y Chen 2011 * * * * * * * *
20 Q Lin 2011 * * * * * * * *
21 PY Chang 2012 * * * * * * *
22 MS Eskander 2012 * * * * * * *
23 Y Liu 2012 * * * * * * * *
24 Ya Liu 2012 * * * * * * *
25 D Lubelski 2013 * * * * * *
26 L Yang 2013 * * * * * * *
27 M Ohashi 2014 * * * * * *
28 DK Son 2014 * * * * * *
29 FL Wu 2014 * * * * * * * *
30 M Bydon 2014 * * * * * * *
31 T Maeno 2014 * * * * * * * *
32 KL Tung 2015 * * * * * * *
33 M Macki 2015 * * * * * * * *
34 DJ Blizzard 2015 * * * * * * * *
35 H Wang 2015 * * * * * * * *
36 CH Lim 2016 * * * * * * * *
37 H Chen 2016 * * * * *
38 S Takenaka 2016 * * * * * * * *
39 SH Lee 2016 * * * * * * * *
40 DJ Blizzard 2016 * * * * * * * *
41 M Koda 2016 * * * * * * * *
42 M Machino 2016 * * * * * * * *
43 MG Fehlings 2016 * * * * * * *
44 X Liu 2016 * * * * * * *
45 KC Kang 2017 * * * * * * * *
46 S Nori 2017 * * * * * * * *
47 T Kratzig 2017 * * * * * * * *
48 Z Li 2017 * * * * * * * *
49 G Chen 2018 * * * * * * * *
50 H Miyamoto 2018 * * * * * * * *
51 YJ Zhao 2018 * * * * * *
52 HT Wu 2018 * * * * * * *
53 Y Yang 2018 * * * * * * *
54 K Sun 2019 * * * * * * * *
55 SC Wagner 2019 * * * * * * * *
56 Y Kobayashi 2019 * * * * * *
57 Z Yu 2019 * * * * * *
58 Z Pennington 2019 * * * * * * * *
59 Z Pennington 2019 * * * * * * *
60 Y Ha 2019 * * * * * * * *
61 SQ Li 2019 * * * * * * *
62 C Zhou 2019 * * * * * * * *
63 D Lubelski 2020 * * * * * *
64 JK Houten 2020 * * * * * * * *
65 X He 2020 * * * * * *
66 FMD Pont 2021 * * * * * * *
67 H Wang 2021 * * * * *
68 RC Hofler 2021 * * * * * * * *
69 Y Liu 2021 * * * * * *
70 Z Pennington 2021 * * * * * *
71 M Takano 2021 * * * * * * * *
72 M Funaba 2021 * * * * *
73 S Odate 2021 * * * * * * * *
74 B Benek 2021 * * * * * * *
75 RC Huang 2022 * * * * * *
76 Y Yang 2022 * * * * * * * *
77 YS Saadeh 2022 * * * * *
78 L Papavero 2022 * * * * * *
79 A Biczok 2022 * * * * * * *
80 F Liu 2022 * * * * * *
81 H Nakashima 2022 * * * * * * *
82 AA Shah 2022 * * * * * * * *
83 C Li 2022 * * * * * * * *
84 J Tian 2022 * * * * * * *
85 J Kim 2022 * * * * * *
86 N Nagoshi 2023 * * * * * *
87 KC Kang 2023 * * * * * * * *
88 N Kim 2023 * * * * * *
89 DJ Levi 2023 * * * * * * *
90 I Uzunoglu 2023 * * * * * * *
91 J Liu 2023 * * * * * * *
92 AAiba 2023 * * * * * * *
93 O Bakr 2023 * * * * * * *
94 H Zhong 2023 * * * * * *
95 TH Tu 2024 * * * * * *
96 M Hashimoto 2024 * * * * * *
97 S Basu 2024 * * * * * * *

Table 3.

General characteristics of studies included in the review

No. Author Year Country Sample size Type Age (yr) M:F Palsy incidence Procedure Follow-up
1 K Yonenobu 1991 Japan 384 Retrospective cohort study 56.7 298:86 13 ACDF; LP 6.1 yr
2 N Tsuzuki 1993 Japan 198 Retrospective cohort study 59 NA 20 PCDF; LP 54 mo
3 K Satomi 1994 Japan 51 Retrospective cohort study 54.7 44:7 4 LP 7.8 yr
4 Y Uematsu 1998 Japan 365 Retrospective cohort study NA NA 20 LP 48 mo
5 K Hirabayashi 1999 Japan 87 Retrospective cohort study 57 76:11 6 LP 7 yr
6 CC Edwards 2000 USA 18 Retrospective cohort study 54 13:5 1 LP 18 mo
7 E Wada 2001 Japan 47 Retrospective cohort study 54.3±9.2 NA 5 ACDF; LP 12 yr
8 K Chiba 2002 Japan 141 Retrospective cohort study 56 NA 11 LP 2 yr
9 M Ikenaga 2005 Japan 549 Retrospective cohort study NA NA 18 ACDF; LP 12 mo
10 K Kaneko 2006 Japan 66 Retrospective cohort study 67 38:28 5 LP 2 yr
11 Y Liu 2009 China 28 Retrospective cohort study 53.5 19:09 1 ACDF; LP 17.3 mo
12 M Hashimoto 2010 Japan 199 Retrospective cohort study NA NA 17 ACDF; LP 15 mo
13 M Yanase 2010 Japan 153 Retrospective cohort study 59.8 NA 9 LP 12 mo
14 Q Guo 2010 China 53 Retrospective cohort study 53.4±9.5 35:18 1 ACDF 37.3/7 mo
15 XF Lian 2010 China 105 Prospective cohort study 60.3 63:42 2 ACDF 31.5 mo
16 K Kotil 2011 Turkey 25 Retrospective cohort study 60.4 19:6 3 ACDF 3.1 yr
17 X Zhao 2011 China 82 Retrospective cohort study 57.6 47:35 2 PCDF; LP 41.6 mo
18 JM Highsmith 2011 USA 56 Retrospective cohort study 59.5 NA 2 PCDF; LP 41.8 mo
19 Y Chen 2011 China 75 Retrospective cohort study NA NA 6 ACDF; PCDF; LP 48 mo
20 Q Lin 2011 China 120 Retrospective cohort study 58.3±9.8 81:39 5 ACDF 24 mo
21 PY Chang 2012 Taiwan 364 Retrospective cohort study 55.9±12 224:140 12 ACDF; LP; Global 12 mo
22 MS Eskander 2012 USA 176 Retrospective cohort study 49.7±11.4 NA 12 ACDF NA
23 Y Liu 2012 China 286 Retrospective cohort study 53.8±7.2 166:120 22 ACDF 24 mo
24 Ya Liu 2012 China 180 Retrospective cohort study 46.9±6.8 109:71 8 ACDF 26.3 mo
25 D Lubelski 2013 USA 98 Retrospective cohort study 59.5±12 NA 12 ACDF; PCDF; LP NA
26 L Yang 2013 China 141 Retrospective cohort study 57.9±8.2 106:35 14 LP; Laminectomy 24 mo
27 M Ohashi 2014 Japan 236 Prospective cohort study 63.8±11.2 168:68 10 LP 24 mo
28 DK Son 2014 South Korea 62 Retrospective cohort study 61.5 44:18 1 LP 12 mo
29 FL Wu 2014 China 102 Retrospective cohort study 58.4 76:26 16 LP 16.3 mo
30 M Bydon 2014 USA 41 Retrospective cohort study 64±10.5 24:17 9 PCDF 26.7 mo
31 T Maeno 2014 Japan 100 Retrospective cohort study 69 69:31 5 LP 4.1 yr
32 KL Tung 2015 Hong Kong 29 Retrospective cohort study 64.3 20:09 2 LP 48 mo
33 M Macki 2015 USA 511 Retrospective cohort study NA NA 43 PCDF 36 mo/34.5
34 DJ Blizzard 2015 USA 54 Retrospective cohort study 59±9.5 35:19 13 PCDF; LP 6 mo
35 H Wang 2015 China 161 Retrospective cohort study 61.8±9.3 108:53 8 ACDF 3.7/1.3 yr
36 CH Lim 2016 South Korea 710 Retrospective cohort study 59 477:233 36 ACDF; PCDF; LP; Global 25.8 mo
37 H Chen 2016 China 105 Retrospective cohort study 61 84:21 13 LP
38 S Takenaka 2016 Japan 800 Prospective cohort study 64.5 543:257 54 PCDF 27.4 mo
39 SH Lee 2016 South Korea 190 Retrospective cohort study 59.5±11.8 105:85 30 PCDF; LP 38.5 mo
40 DJ Blizzard 2016 USA 72 Retrospective cohort study NA NA 13 PCDF; LP 18.7 mo
41 M Koda 2016 Japan 48 Retrospective cohort study 61 36:12 4 ACDF; PCDF; LP 48.8 mo
42 M Machino 2016 Japan 505 Prospective cohort study 66.6 311:194 7 LP 26.5/12.5 mo
43 MG Fehlings 2016 Canada 266 Prospective cohort study 60.9±11.1 180:86 7 PCDF; LP 24 mo
44 X Liu 2016 China 67 Retrospective cohort study 59.5±9 51:16 2 PCDF; LP 40/11 mo
45 KC Kang 2017 South Korea 70 Retrospective cohort study 60.3 47:23 10 PCDF 12 mo
46 S Nori 2017 Japan 263 Retrospective cohort study 63±10.8 190:73 11 PCDF 12 mo
47 T Kratzig 2017 Germany 1,708 Prospective cohort study 61±11.6 777:931 82 PCDF; Global 36 mo
48 Z Li 2017 China 70 Retrospective cohort study 56.8 49:21 3 ACDF 24 mo
49 G Chen 2018 China 118 Retrospective cohort study 58 94:24 12 LP 36 mo
50 H Miyamoto 2018 Japan 31 Retrospective cohort study 66.7 17:14 10 PCDF; Global 30/10 mo
51 YJ Zhao 2018 China 71 Retrospective cohort study 59±16 39:32 10 PCDF 22.5/6.2 mo
52 HT Wu 2018 China 168 Retrospective cohort study 50.5±17 89:78 9 ACDF 21.5 mo
53 Y Yang 2018 China 100 Retrospective cohort study 49.6±5.3 48:52 11 ACDF NA
54 K Sun 2019 China 80 Retrospective cohort study 57.2±12 42:38 5 ACDF; LP 12 mo
55 SC Wagner 2019 USA 196 Retrospective cohort study 59 96:100 10 ACDF 7 mo
56 Y Kobayashi 2019 Japan 174 Retrospective cohort study 63.3 83:31 10 PCDF 12.3 mo
57 Z Yu 2019 Taiwan 44 Prospective cohort study 61±10.2 25:19 4 PCDF; LP 19 mo
58 Z Pennington 2019 USA 221 Retrospective cohort study 63 119:102 27 PCDF 12.9 mo
59 Z Pennington 2019 USA 242 Retrospective cohort study 62.4 160:82 42 PCDF 27.9 mo
60 Y Ha 2019 South Korea 91 Retrospective cohort study 60.5 69:22 9 PCDF; LP 38.6 mo
61 SQ Li 2019 China 158 Retrospective cohort study 56.9±8.5 83:75 5 ACDF 21.4/7.6 mo
62 C Zhou 2019 China 52 Retrospective cohort study 55.3 30:22 0 ACDF; LP 15.9 mo
63 D Lubelski 2020 USA 77 Retrospective cohort study 64.5±7.6 61:16 77 PCDF 17.6/23.6 mo
64 JK Houten 2020 USA 642 Retrospective cohort study 65 325:317 18 ACDF; PCDF 20/10.7 mo
65 X He 2020 China 104 Retrospective cohort study 58.5±8.1 51:53 8 PCDF; LP 35.2/10.2 mo
66 FMD Pont 2021 Argentina 20 Retrospective cohort study 58 12:8 1 LP 9 mo
67 H Wang 2021 China 184 Retrospective cohort study 63±11.4 76:108 26 PCDF 12 mo
68 RC Hofler 2021 USA 190 Retrospective cohort study NA NA 53 PCDF 19.9 mo
69 Y Liu 2021 China 90 Retrospective cohort study 56.12±12.2 43:47 8 PCDF 16/3.5 mo
70 Z Pennington 2021 USA 77 Retrospective cohort study 64 52:25 77 PCDF 11 mo
71 M Takano 2021 Japan 108 Retrospective cohort study 66.1±11.7 88:20 5 LP 12 mo
72 M Funaba 2021 Japan 1,176 Prospective cohort study 67.6±4.4 663:513 31 ACDF; PCDF; LP; Global NA
73 S Odate 2021 Japan 839 Retrospective cohort study 59.1±11.6 NA 57 ACDF 55/17 mo
74 B Benek 2021 Turkey 52 Retrospective cohort study 61.9 41:11 3 PCDF; LP 20 mo
75 RC Huang 2022 USA 32 Retrospective cohort study 67.8 24:08 2 PCDF 15.2 mo
76 Y Yang 2022 China 76 Retrospective cohort study 61±8.2 40:36 9 PCDF; LP 18/2.6 mo
77 YS Saadeh 2022 USA 72 Retrospective cohort study 62.5 46:26 72 ACDF; PCDF 12 mo
78 L Papavero 2022 Germany 23 Prospective cohort study 72 17:6 1 Global 12 mo
79 A Biczok 2022 Germany 29 Prospective cohort study 71.5 16:13 1 PCDF 3 mo
80 F Liu 2022 China 98 Retrospective cohort study 62.2±7.7 56:42 9 LP 19.6/5.2 mo
81 H Nakashima 2022 Japan 189 Prospective cohort study 64±11 134:55 15 PCDF; LP 24 mo
82 AA Shah 2022 USA 1,024 Retrospective cohort study 60 588:436 52 ACDF; PCDF NA
83 C Li 2022 China 17 Retrospective cohort study 57±10.5 12:5 1 PCDF 16/3.3 mo
84 J Tian 2022 China 52 Retrospective cohort study 62±9.2 20:32 5 LP 15 mo
85 J Kim 2022 USA 264 Retrospective cohort study 62±11.5 184:80 14 PCDF; LP 1 mo
86 N Nagoshi 2023 Japan 253 Retrospective cohort study 61±9.2 180:73 19 ACDF; PCDF; LP 24 mo
87 KC Kang 2023 South Korea 193 Retrospective cohort study 59.7±11.9 135:58 12 LP 38.1/15.1 mo
88 N Kim 2023 South Korea 101 Retrospective cohort study 66.2±10 82:19 16 LP 22.3/10.3 mo
89 DJ Levi 2023 USA 272 Retrospective cohort study 59.9 NA 7 PCDF; LP 24 mo
90 I Uzunoglu 2023 Turkey 177 Retrospective cohort study 58.1±11.8 117:60 22 LP 6 mo
91 J Liu 2023 China 122 Retrospective cohort study 60.1±3.8 73:49 9 ACDF; LP 26.8/3.1 mo
92 AAiba 2023 Japan 801 Retrospective cohort study 64.4±11.9 559:242 42 ACDF 12 mo
93 O Bakr 2023 USA 135 Retrospective cohort study 63 74:61 12 PCDF; LP 24 mo
94 H Zhong 2023 China 116 Retrospective cohort study 57.2±12.1 61:55 9 ACDF; PCDF; LP 38.4/21 mo
95 TH Tu 2024 Taiwan 42 Retrospective cohort study 59.8±10.3 27:15 13 Global 45.8 mo
96 M Hashimoto 2024 Japan 1,434 Retrospective cohort study 62±12.3 575:859 76 ACDF 49/34 mo
97 S Basu 2024 India 60 Retrospective cohort study 52.2±12.1 38:22 9 PCDF; LP 24 mo

Values are presented as number or mean±standard deviation, unless otherwise stated.

M, male; F, female; ACDF, anterior cervical decompression and fusion; LP, laminoplasty; NA, not applicable; PCDF, posterior cervical decompression and fusion.